On Apr 17, 2018 ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) Sellers Rose Their Shorts By 4.12%

April 17, 2018 - By Joseph Norton

ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) had an increase of its shares shorted by 4.12%. FINRA announced in April ACUR’s total 20,200 shares shorted. Previously was reported up change of 4.12% from 19,400 shares. 1 days will cost ACUR With 16,900 average volume to recover its previous position. ACURA PHARMACEUTICALS INC’s shares shorted float is 0.28%.

Its shares touched $0.4201 on during the last trading session after 7.87% change.Acura Pharmaceuticals, Inc. has volume of shares. Since April 17, 2017 ACUR has 0.00% and is . ACUR underperformed the S&P 500 by 11.55%.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse.The firm is valued at $8.74 million. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.Currently it has negative earnings. The firm has six additional opioid products in various stages of formulation development.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: